Share Your Research, Maximize Your Social Impacts
Sudden hearing loss in a patient of Hodgkin's lymphoma following vinblastine chemotherapy: a rare case report and review of the literature
Journal: International Journal of Basic & Clinical Pharmacology (Vol.3, No. 5)Publication Date: 2014-10-01
Authors : Akhil Kapoor; Satya Narayan; Raj Kumar Nirban; Sitaram Maharia; Harvindra Singh Kumar;
Page : 912-913
Keywords : Hodgkin's lymphoma; Ototoxicity; Vinblastine;
Source : Download
Find it from : Google Scholar
Abstract
Ototoxicity is a well-known complication of certain chemotherapeutic agents. There have been few reports of ototoxicity following administration of vincristine. However, vinblastine has seldom been implicated causing ototoxicity. We report a case of sudden bilateral hearing loss in a 32-year-old male patient of classical Hodgkin's lymphoma following standard adriamycin, bleomycin, vinblastine, dacarbazine chemotherapy.
Other Latest Articles
- Imatinib resistance in chronic myelogenous leukemia: an emerging challenge
- The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus
- Prescription audit study in a tertiary care hospital using the anatomical therapeutic chemical and defined daily dose classification concept
- Medication package inserts' usefulness for Sudanese pharmacists and patients: pharmacists perspective
- Drug utilization review of anticancer drugs in cancer outpatient department of the Government Medical College, Aurangabad
Last modified: 2014-10-25 16:50:48